Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) traded down 4% during trading on Tuesday . The stock traded as low as $19.58 and last traded at $19.58. 708 shares were traded during trading, a decline of 99% from the average session volume of 81,598 shares. The stock had previously closed at $20.40.
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. initiated coverage on shares of Ascentage Pharma Group International in a research note on Thursday, March 27th. They issued an “overweight” rating for the company.
Get Our Latest Report on Ascentage Pharma Group International
Ascentage Pharma Group International Stock Down 9.8 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Stories
- Five stocks we like better than Ascentage Pharma Group International
- Earnings Per Share Calculator: How to Calculate EPS
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- Breakout Stocks: What They Are and How to Identify Them
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- Golden Cross Stocks: Pattern, Examples and Charts
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
